Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aspen Aerogels Inc (ASPN) vs McKesson Corporation (MCK) Price & Performance

Aspen Aerogels IncTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

Aspen Aerogels Inc vs McKesson Corporation — how do they compare? Aspen Aerogels Inc trades at $6.14 (market cap $509.55M), while McKesson Corporation trades at $897.31 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 206.3× Aspen Aerogels Inc's market cap, and McKesson Corporation pays a 0.42% dividend while Aspen Aerogels Inc pays none. Which is the better fit depends on your goals.

ASPNMCK
Market Cap
$509.55M$105.14B
Sector
TechnologyHealth
52-Week High
$8.82$995.69
52-Week Low
$2.57$659.01
Enterprise Value
$482.96M$111.67B
Dividend Yield
0.42%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aspen Aerogels Inc

No Aura AI signal available yet.

McKesson Corporation

McKesson (MCK) trades at $879.87, up 1.18% today, with strong momentum from recent earnings beats and raised guidance. The stock shows bullish technical signals, supported by robust revenue growth and solid cash flow generation. Recent news highlights strength in specialty drugs and oncology, driving positive sentiment.

Outlook remains favorable with a consensus price target of $990.67, though thin profit margins and high liabilities pose risks. Continued execution on growth initiatives and cost discipline are key for sustained upside, while macroeconomic pressures and competitive dynamics require monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aspen Aerogels Inc

Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.

Read more on ASPN

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK